The US Food and Drug Administration (FDA) has approved a new molecular assay, ID CORE XT (Progenika Biopharma), for use in transfusion medicine to help determine blood compatibility between donor and ...
If blood with poorly matched antibodies is transfused, the procedure is more likely to lead to red blood cell destruction and a transfusion reaction, the agency explained. HealthDay News — The US Food ...
The FDA approved its first diagnostic test that reports genotypes as a final result when evaluating blood compatibility for transfusions: a molecular assay that can be used to match donors with ...
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...
Six years after the fall of Theranos, companies are again exploring innovation in blood testing. The medical community is reacting with cautious optimism. Six years after the fall of Theranos, ...
In a breakthrough that could transform how we understand blood compatibility and genetic mutations, French scientists have identified a new and ultra-rare human blood group, officially recognized as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback